Clinical Trial Update: Effect of Ev.FV on Wound Healing in Dystrophic Epidermolysis Bullosa [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Ev.FV for wound healing in patients with dystrophic epidermolysis bullosa is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dystrophic Epidermolysis Bullosa

Drugs mentioned

• Ev.FV

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Dystrophic Epidermolysis Bullosa, Wound Heal | Phase 1, Phase 2 | Status: RECRUITING